#BTCY Target : $3.60 - 3.80 uPto 22%

Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA



Support Level 1 : USD 3.95
Support Level 2 : USD 3.60
Resistance 1 : USD 2. 80
Resistance 2 : USD 2.30

**Disclaimer - not financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
I would appreciate your feedback on my analysis. Do not view this idea as a recommendation for trading or investing.

İşlem kapandı: hedefe ulaştı:

I'm Done and Happy to Hear about your Ideas. .